The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Kruppel-like Factor 4 Is a Mediator of Proinflammatory Signaling in Macrophages
Open accessAbstract
Activation of macrophages is important in chronic inflammatory disease states such as atherosclerosis. Proinflammatory cytokines such as interferon-gamma (IFN-gamma), lipopolysaccharide (LPS), or tumor necrosis factor-alpha can promote macrophage activation. Conversely, anti-inflammatory factors such as transforming growth factor-beta1 (TGF-beta1) can decrease proinflammatory activation. The molecular mediators regulating the balance of these opposing effectors remain incompletely understood. Herein, we identify Kruppel-like factor 4 (KLF4) as being markedly induced in response to IFN-gamma, LPS, or tumor necrosis factor-alpha and decreased by TGF-beta1 in macrophages. Overexpression of KLF4 in J774a macrophages induced the macrophage activation marker inducible nitric-oxide synthase and inhibited the TGF-beta1 and Smad3 target gene plasminogen activator inhibitor-1 (PAI-1). Conversely, KLF4 knockdown markedly attenuated the ability of IFN-gamma, LPS, or IFN-gamma plus LPS to induce the iNOS promoter, whereas it augmented macrophage responsiveness to TGF-beta1 and Smad3 signaling. The KLF4 induction of the iNOS promoter is mediated by two KLF DNA-binding sites at -95 and -212 bp, and mutation of these sites diminished induction by IFN-gamma and LPS. We further provide evidence that KLF4 interacts with the NF-kappaB family member p65 (RelA) to cooperatively induce the iNOS promoter. In contrast, KLF4 inhibited the TGF-beta1/Smad3 induction of the PAI-1 promoter independent of KLF4 DNA binding through a novel antagonistic competition with Smad3 for the C terminus of the coactivator p300/CBP. These findings support an important role for KLF4 as a regulator of key signaling pathways that control macrophage activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
Massague, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,966
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., & Murphy, W. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9730 · Cited by 1,064
Transcriptional Activators of TGF-β Responses: Smads
Derynck, R., Zhang, Y., & Feng, X.-H. (1998) · Cell · doi:10.1016/s0092-8674(00)81696-7 · Cited by 1,029
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
CREB-binding Protein and p300 in Transcriptional Regulation
Vo, N., & Goodman, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000025200 · Cited by 866
The role of nitric oxide in cancer
XU, W., LIU, L. Z., LOIZIDOU, M., AHMED, M., & CHARLES, I. G. (2002) · Cell Research · doi:10.1038/sj.cr.7290133 · Cited by 826
CREB-binding protein/p300 are transcriptional coactivators of p65
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., & Collins, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2927 · Cited by 816
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
Ulloa, L., Doody, J., & Massagué, J. (1999) · Nature · doi:10.1038/17826 · Cited by 812
Klf4 is a transcription factor required for establishing the barrier function of the skin
Segre, J. A., Bauer, C., & Fuchs, E. (1999) · Nature Genetics · doi:10.1038/11926 · Cited by 788
KLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation
SenBanerjee, S., Lin, Z., Atkins, G. B., Greif, D. M., Rao, R. M., Kumar, A., Feinberg, M. W., Chen, Z., Simon, D. I., Luscinskas, F. W., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031132 · Cited by 723
Self-citationShields, J. M., Christy, R. J., & Yang, V. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20009 · Cited by 652
Nitric oxide synthase activity in human breast cancer
Thomsen, L., Miles, D., Happerfield, L., Bobrow, L., Knowles, R., & Moncada, S. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.274 · Cited by 626
Krüppel-like Factors: Three Fingers in Many Pies
Bieker, J. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100043200 · Cited by 604
Katz, J. P., Perreault, N., Goldstein, B. G., Lee, C. S., Labosky, P. A., Yang, V. W., & Kaestner, K. H. (2002) · Development · doi:10.1242/dev.129.11.2619 · Cited by 594
Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene
Nuez, B., Michalovich, D., Bygrave, A., Ploemacher, R., & Grosveld, F. (1995) · Nature · doi:10.1038/375316a0 · Cited by 551
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle
Kolios, G., Valatas, V., & Ward, S. G. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01984.x · Cited by 541
Feng, X.-H., Zhang, Y., Wu, R.-Y., & Derynck, R. (1998) · Genes & Development · doi:10.1101/gad.12.14.2153 · Cited by 525
TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300
Janknecht, R., Wells, N. J., & Hunter, T. (1998) · Genes & Development · doi:10.1101/gad.12.14.2114 · Cited by 507
Mallat, Z., Gojova, A., Marchiol-Fournigault, C., Esposito, B., Kamaté, C., Merval, R., Fradelizi, D., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh2201.099415 · Cited by 490
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed · Cited by 461
The biology of the mammalian Krüppel-like family of transcription factors
Dang, D. T., Pevsner, J., & Yang, V. W. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00059-5 · Cited by 458
Titheradge, M. A. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00031-6 · Cited by 457
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
Horvai, A. E., Xu, L., Korzus, E., Brard, G., Kalafus, D., Mullen, T.-M., Rose, D. W., Rosenfeld, M. G., & Glass, C. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1074 · Cited by 422
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 421
LKLF: A Transcriptional Regulator of Single-Positive T Cell Quiescence and Survival
Kuo, C. T., Veselits, M. L., & Leiden, J. M. (1997) · Science · doi:10.1126/science.277.5334.1986 · Cited by 419
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 378
Exogenous Interferon-γ Enhances Atherosclerosis in Apolipoprotein E−/− Mice
Whitman, S. C., Ravisankar, P., Elam, H., & Daugherty, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64820-1 · Cited by 378
Libby, P., & Pober, J. S. (2001) · Immunity · doi:10.1016/s1074-7613(01)00119-4 · Cited by 375
Role of Krüppel-like Factor 15 (KLF15) in Transcriptional Regulation of Adipogenesis
Mori, T., Sakaue, H., Iguchi, H., Gomi, H., Okada, Y., Takashima, Y., Nakamura, K., Nakamura, T., Yamauchi, T., Kubota, N., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410515200 · Cited by 340
CBP-induced stimulation of c-Fos activity is abrogated by E1A.
Bannister, A. J., & Kouzarides, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00157.x · Cited by 337
Lutgens, E., Gijbels, M., Smook, M., Heeringa, P., Gotwals, P., Koteliansky, V. E., & Daemen, M. J. A. P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000019729.39500.2f · Cited by 313
Sheppard, K.-A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E., & Collins, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29291 · Cited by 305
Gao, J., Morrison, D. C., Parmely, T. J., Russell, S. W., & Murphy, W. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1226 · Cited by 303
Buono, C., Come, C. E., Stavrakis, G., Maguire, G. F., Connelly, P. W., & Lichtman, A. H. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000059419.11002.6e · Cited by 289
Nagano, H., Mitchell, R. N., Taylor, M. K., Hasegawa, S., Tilney, N. L., & Libby, P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119564 · Cited by 275
Kuhlencordt, P. J., Chen, J., Han, F., Astern, J., & Huang, P. L. (2001) · Circulation · doi:10.1161/01.cir.103.25.3099 · Cited by 251
The Kru¨ppel-like Factor KLF15 Regulates the Insulin-sensitive Glucose Transporter GLUT4
Gray, S., Feinberg, M. W., Hull, S., Kuo, C. T., Watanabe, M., Banerjee, S. S., DePina, A., Haspel, R., & Jain, M. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201304200 · Cited by 249
Self-citationStein, R. W., Corrigan, M., Yaciuk, P., Whelan, J., & Moran, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4421-4427.1990 · Cited by 244
DNA tumor virus transforming proteins and the cell cycle
Moran, E. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80342-9 · Cited by 237
Ghosh, A. K., Yuan, W., Mori, Y., Chen, S.-J., & Varga, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004709200 · Cited by 225
Nitric oxide signaling in colon cancer chemoprevention
Rao, C. V. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.05.022 · Cited by 216
Immunologic basis of transplant-associated arteriosclerosis.
Shi, C., Lee, W. S., He, Q., Zhang, D., Fletcher, D. L., Newell, J. B., & Haber, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4051 · Cited by 215
Shen, X., Hu, P. P.-C., Liberati, N. T., Datto, M. B., Frederick, J. P., & Wang, X.-F. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3309 · Cited by 215
Detmers, P. A., Hernandez, M., Mudgett, J., Hassing, H., Burton, C., Mundt, S., Chun, S., Fletcher, D., Card, D. J., Lisnock, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3430 · Cited by 207
GATA-3-dependent enhancer activity in IL-4 gene regulation.
Ranganath, S. H., Ouyang, W., Bhattarcharya, D., Sha, W. C., Grupe, A., Peltz, G., & MURPHY, K. M. M. (1998) · PubMed · Cited by 201
Transforming Growth Factor-β1 Inhibition of Macrophage Activation Is Mediated via Smad3
Werner, F., Jain, M. K., Feinberg, M. W., Sibinga, N. E. S., Pellacani, A., Wiesel, P., Chin, M. T., Topper, J. N., Perrella, M. A., & Lee, M.-E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004536200 · Cited by 179
Self-citationTGF-β and the Smad signal transduction pathway
Mehra, A., & Wrana, J. L. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-161 · Cited by 175
Studies of IFN-Induced Transcriptional Activation Uncover the Jak-Stat Pathway
DARNELL, J. E. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.549 · Cited by 170
Werner, F., Feinberg, M. W., Jain, M. K., Sibinga, N. E. S., Wiesel, P., Wang, H., Topper, J. N., Perrella, M. A., & Lee, M.-E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002664200 · Cited by 168
Self-citationCutting Edge: GATA-3-Dependent Enhancer Activity in IL-4 Gene Regulation
Ranganath, S., Ouyang, W., Bhattarcharya, D., Sha, W. C., Grupe, A., Peltz, G., & Murphy, K. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3822 · Cited by 166
Adenovirus E1A targets key regulators of cell proliferation.
Dyson, N. J., & Harlow, E. (1992) · PubMed · Cited by 147
Geiman, D. E. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.5.1106 · Cited by 127
TGF-βs and TGF-β receptors in atherosclerosis
McCaffrey, T. A. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00034-9 · Cited by 124
The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling
Itoh, S., Ericsson, J., Nishikawa, J., Heldin, C. H., & ten Dijke, P. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4291 · Cited by 120
Koh, K. P., Wang, Y., Yi, T., Shiao, S. L., Lorber, M. I., Sessa, W. C., Tellides, G., & Pober, J. S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21767 · Cited by 108
Song, A., Chen, Y.-F., Thamatrakoln, K., Storm, T. A., & Krensky, A. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80010-2 · Cited by 105
Essential Role for Smad3 in Regulating MCP-1 Expression and Vascular Inflammation
Feinberg, M. W., Shimizu, K., Lebedeva, M. A., Haspel, R. L., Takayama, K., Chen, Z., Frederick, J. P., Wang, X.-F., Simon, D. I., Libby, P., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000119170.70818.4f · Cited by 105
Self-citationTissue-specific targeting of gytokine unresponsiveness in transgenic mice
Dighe, A. S., Campbell, D., Hsieh, C., Clarke, S., Greaves, D. R., Gordon, S., MURPHY, K. M. M., & Schreiber, R. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90136-1 · Cited by 95
Räisänen-Sokolowski, A. K., Glysing-Jensen, T., Koglin, J., & Russell, M. E. (1998) · Europe PMC (PubMed Central) · Cited by 89
An Emerging Role for Krüppel-Like Factors in Vascular Biology
Feinberg, M. W., Lin, Z., Fisch, S., & Jain, M. K. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.06.005 · Cited by 83
Self-citationIsolation, Genomic Structure, and Expression of Human Erythroid Krüppel-Like Factor (EKLF)
Bieker, J. J. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.347 · Cited by 82
Perrella, M. A., Patterson, C., Tan, L., Yet, S., Hsieh, C.-M., Yoshizumi, M., & Lee, M.-E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13776 · Cited by 79
Functional Interaction between Coactivators CBP/p300, PCAF, and Transcription Factor FKLF2
Song, C.-Z., Keller, K. L., Murata, K., Asano, H., & Stamatoyannopoulos, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108826200 · Cited by 77
Warke, V. G., Nambiar, M. P., Krishnan, S. K., Tenbrock, K., Geller, D. A., Koritschoner, N. P., Atkins, J. L., Färber, D. L., & Tsokos, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300787200 · Cited by 73
Zhang, N., Weber, A., Li, B., Lyons, R. C., Contag, P. R., Purchio, A. F., & West, D. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6307 · Cited by 69
Alley, E. W., Murphy, W. J., & Russell, S. W. (1995) · Gene · doi:10.1016/0378-1119(94)00892-v · Cited by 47
Wong, H. K., & Ziff, E. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4910-4920.1994 · Cited by 41
Noti, J. D., Johnson, A. K., & Dillon, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412627200 · Cited by 37
STAT1 Is Required for IFN-γ-Mediated Gut-Enriched Krüppel-like Factor Expression
Chen, Z. Y. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5633 · Cited by 24
Cited by
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2467 · Cited by 1,024
Mammalian Krüppel-Like Factors in Health and Diseases
McConnell, B. B., & Yang, V. W. (2010) · Physiological Reviews · doi:10.1152/physrev.00058.2009 · Cited by 1,018
Novel Markers to Delineate Murine M1 and M2 Macrophages
Jablonski, K. A., Amici, S. A., Webb, L. M., Ruiz-Rosado, J. D. D., Popovich, P. G., Partida-Sanchez, S., & Guerau-de-Arellano, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145342 · Cited by 978
Krüppel-like factor 4 regulates macrophage polarization
Liao, X., Sharma, N., Kapadia, F., Zhou, G., Lu, Y., Hong, H., Paruchuri, K., Mahabeleshwar, G. H., Dalmas, E., Venteclef, N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45444 · Cited by 778
Self-citationKrüppel-like factor 4 (KLF4): What we currently know
Ghaleb, A. M., & Yang, V. W. (2017) · Gene · doi:10.1016/j.gene.2017.02.025 · Cited by 523
Metadata
- Authors
- Feinberg, M. W., Cao, Z., Wara, A. K., Lebedeva, M. A., SenBanerjee, S., & Jain, M. K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 280
- Issue
- 46
- Pages
- 38247-38258
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2066060929
- Cited by
- 292
- References
- 78
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.